Our results showed that paeoniflorin, at similar non-toxic doses as those used in the transcriptomic analysis, reduced the levels of BACH1 (total, nuclear and cytoplasmic levels) in lung and breast cancer cell lines (Fig. 4B and C). This evidence concerns the gene BACH1 and breast carcinoma.